Advisor Group Inc. grew its stake in shares of Core Laboratories N.V. (NYSE:CLB) by 31.1% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 8,417 shares of the oil and gas company’s stock after acquiring an additional 1,998 shares during the quarter. Advisor Group Inc.’s holdings in Core Laboratories N.V. were worth $831,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently bought and sold shares of CLB. Clearbridge Investments LLC raised its position in shares of Core Laboratories N.V. by 3.8% in the 1st quarter. Clearbridge Investments LLC now owns 5,219,879 shares of the oil and gas company’s stock valued at $603,000,000 after purchasing an additional 190,186 shares during the last quarter. WCM Investment Management CA boosted its stake in Core Laboratories N.V. by 7.3% in the 2nd quarter. WCM Investment Management CA now owns 4,433,175 shares of the oil and gas company’s stock worth $448,948,000 after purchasing an additional 303,073 shares in the last quarter. Vanguard Group Inc. grew its position in Core Laboratories N.V. by 1.6% during the 2nd quarter. Vanguard Group Inc. now owns 3,672,865 shares of the oil and gas company’s stock worth $371,950,000 after purchasing an additional 56,807 shares during the last quarter. Sustainable Growth Advisers LP grew its position in Core Laboratories N.V. by 36.9% during the 2nd quarter. Sustainable Growth Advisers LP now owns 2,345,271 shares of the oil and gas company’s stock worth $237,505,000 after purchasing an additional 632,263 shares during the last quarter. Finally, Kayne Anderson Rudnick Investment Management LLC grew its position in Core Laboratories N.V. by 1.3% during the 2nd quarter. Kayne Anderson Rudnick Investment Management LLC now owns 1,702,000 shares of the oil and gas company’s stock worth $172,364,000 after purchasing an additional 22,276 shares during the last quarter.

TRADEMARK VIOLATION WARNING: “Core Laboratories N.V. (CLB) Stake Boosted by Advisor Group Inc.” was first published by Watch List News and is the property of of Watch List News. If you are accessing this report on another domain, it was illegally stolen and reposted in violation of US and international trademark and copyright legislation. The correct version of this report can be viewed at https://www.watchlistnews.com/core-laboratories-n-v-clb-stake-boosted-by-advisor-group-inc/1605160.html.

CLB has been the subject of a number of research analyst reports. Zacks Investment Research cut shares of Core Laboratories N.V. from a “hold” rating to a “sell” rating in a report on Tuesday, September 26th. Piper Jaffray Companies set a $97.00 price objective on shares of Core Laboratories N.V. and gave the stock a “hold” rating in a research note on Wednesday, July 26th. Citigroup Inc. dropped their price objective on shares of Core Laboratories N.V. from $102.00 to $100.00 and set a “neutral” rating on the stock in a report on Wednesday, July 26th. ValuEngine raised shares of Core Laboratories N.V. from a “sell” rating to a “hold” rating in a report on Friday, August 4th. Finally, Royal Bank Of Canada set a $145.00 price objective on shares of Core Laboratories N.V. and gave the company a “buy” rating in a report on Saturday, June 17th. Four equities research analysts have rated the stock with a sell rating, eight have assigned a hold rating and five have issued a buy rating to the stock. The stock has an average rating of “Hold” and an average price target of $113.58.

Core Laboratories N.V. (NYSE:CLB) opened at 98.69 on Tuesday. The firm has a market cap of $4.36 billion, a PE ratio of 60.55 and a beta of 1.63. Core Laboratories N.V. has a one year low of $86.55 and a one year high of $125.83. The stock has a 50 day moving average price of $92.88 and a 200 day moving average price of $103.06.

Core Laboratories N.V. (NYSE:CLB) last posted its quarterly earnings data on Monday, July 24th. The oil and gas company reported $0.52 EPS for the quarter, beating analysts’ consensus estimates of $0.51 by $0.01. Core Laboratories N.V. had a net margin of 11.80% and a return on equity of 49.29%. The company had revenue of $163.90 million for the quarter, compared to analyst estimates of $168.23 million. During the same period in the previous year, the business posted $0.35 earnings per share. Core Laboratories N.V.’s quarterly revenue was up 10.7% on a year-over-year basis. Equities research analysts expect that Core Laboratories N.V. will post $1.99 EPS for the current year.

Core Laboratories N.V. Company Profile

Core Laboratories N.V. provides reservoir description, production enhancement and reservoir management services to the oil and gas industry. The Company operates through three segments: Reservoir Description, Production Enhancement and Reservoir Management. The Reservoir Description segment encompasses the characterization of petroleum reservoir rock, fluid and gas samples.

Want to see what other hedge funds are holding CLB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Core Laboratories N.V. (NYSE:CLB).

Institutional Ownership by Quarter for Core Laboratories N.V. (NYSE:CLB)

Receive News & Ratings for Core Laboratories N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Laboratories N.V. and related companies with Analyst Ratings Network's FREE daily email newsletter.